Global Biomedical Textiles Market Size By Fiber Type (Biodegradable, Non-Biodegradable), By Application (Non-Implantable, Surgical Sutures), By Geographic Scope And Forecast

Biomedical Textiles Market Size And Forecast

Biomedical Textiles Market size was valued at USD 14.06 Billion in 2022 and is projected to reach USD 20.57 Billion by 2030, growing at a CAGR of 6.29% from 2023 to 2030.

Major factors driving the market growth include the increasing number of surgeries, rapid increase in the aging population, high quality of biomedical textiles, and increasing demand for advanced wound dressings are expected to fuel the growth of the Biomedical Textiles Market. The Global Biomedical Textiles Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Biomedical Textiles Market Definition

Biomedical textiles are fibrous textiles intended for use in medical and biological applications. Biocompatible textiles are used in first aid, surgery, and maintaining a disinfected environment. The performance of such textiles depends on their biocompatibility with living tissue and fluids. Biomedical textiles require specific properties such as chemically inert, sterile, non-allergenic, biocompatible, flexible, and non-toxic. Such textiles are used in fields like Dentistry, Surgery, Neurology, and Cardiology. In addition, biomedical textiles produce surgical sutures, tissue implants and artificial organs.

In recent decades, the production of medical textiles, their materials, and the techniques used to manufacture them have evolved significantly. Biomedical implants are used to support or replace damaged tissues and organs. These materials influence how the body repairs, whether in wound closure (sutures) or replacement surgery (vascular grafts or artificial ligaments). Moreover, transplantation is a natural way to replace a defective body part, but it is not always possible for many reasons. So doctors use artificial substitutes (biomaterials) such as fibers. A foreign/synthetic material partially used to replace a part of the body is called a prosthesis, but most people are familiar with artificial knees and hips.

The main characteristic of biomedical textiles is that they fulfill the purpose for which they were designed. For example, sutures may require biodegradable textiles. Artificial ligaments are permanent and may react more strongly with blood cells and surrounding tissue than external bandages, which are temporary and only contact the outer skin tissue. Implantable devices must be biocompatible. Biocompatibility testing evaluates host system response to medical textiles. The results of these tests should be considered in conjunction with the advantages of this device.

Global Biomedical Textiles Market Overview

One of the major factors driving the market is the increasing elderly population in the world. Age-related physiological changes make older people more likely to develop orthopedic, cardiovascular, spinal, and eye diseases. Most of these diseases can be effectively treated with surgical techniques. Therefore, the aging population has increased the demand for surgical interventions. According to the Centers for Disease Control and Prevention (CDC) report, U.S. emergency departments treat falls in 27 million elderly patients yearly. Declining cell function reduces the body’s ability to seal and heal wounds with age.

Chronic lesions such as pressure ulcers are also relatively common in older people. Most people who need sutures, implants, and wound care products are more senior people. The Biomedical Textiles Market is expected to be driven by demand for these products, which will likely increase as the population ages. It is used in advanced materials resistant to various bacteria, fungi, fire, dirt, and water. The development of these substances requires extensive research and development to provide specialized products that meet healthcare specifications. Like producing high-quality fabrics, research, and development costs are high due to labor, technology, and other associated costs. These materials also require efficient machinery, state-of-the-art technology, and suitable raw materials.

Also, the raw materials used in antimicrobial biomedical textiles contain large excesses of fiber aggregates and antimicrobial agents such as silver, copper, and quaternary ammonium. It is also a complex process that requires market participants to oversee producing high-quality fibers. Therefore, these textiles’ high research and development costs restrain market growth. Smart biomedical textiles are wearable materials that embed semiconductors and sensors in the fabric—using these textiles in patient clothing aids in coronary charge, blood pressure, and pulse screening. It also helps screen body temperature, respiratory rate, humidity, and pH.

Global Biomedical Textiles MarketSegmentation Analysis

The Global Biomedical Textiles Market is segmented on the basis Fiber Type, Application, And Geography.

Biomedical Textiles Market, By Fiber Type

• Biodegradable
• Non-Biodegradable

Based on Fiber Type, The market is segmented into Biodegradable and Non-Biodegradable. The non-biodegradable segment holds a large number of share in the market because the body slowly absorbs non-biodegradable fiber, and it takes six months or more to break it down. The non-biodegradable fiber segment exists due to the widespread use of non-biodegradable fibers in various applications, including bandages, surgical sutures, hard and soft tissue implants, and extracorporeal devices. Non-biodegradable fibers include polypropylene, polyethylene, rayon, polyamide, and polyester.

Biomedical Textiles Market, By Application

• Non-Implantable
• Surgical Sutures
• Others

Based on Application, The market is segmented into Non-Implantable, Surgical Sutures, and Others. The non-implantable segment holds a large number of share in the market because the non-implantable applications include a variety of polyethylene, cotton, viscose, polyamide, and spandex bandages. The fabrics used in these products are non-woven, woven, or knitted. The primary raw materials for these products are viscose and cotton. Conventional wound care includes first aid to prevent bacterial infection. These bandages have cohesive, elastic; tubular; triangular, and gauze used for support, fixation, and compression of the application.

Biomedical Textiles Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, The Global Biomedical Textiles Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North American region holds a large market share because of consumer awareness of biomedical products; increasing demand for quality products, with most of the major players in the market focusing on the country. Safety regulations and continued investment in research and development activities to develop advanced fabrics also support the market’s growth.

Strong export markets, sophisticated and powerful products, and expanding medical and healthcare industries are also some of the factors driving the market. Whereas the Asia Pacific is the fastest-growing region in the market because emerging markets such as China, India, and Singapore are expected to drive market growth due to rising healthcare costs and increasing disposable income. Moreover, increasing spending on installing technical textile equipment will directly boost the demand for biomedical textiles.

Key Players

The “Global Biomedical Textiles Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Smith & Nephew, DSM, B. Braun Melsungen AG, Confluent Medical Technologies, Secant Group, Meister & Cie AG, Johnson & Johnson, Medlin, and BSN Medical.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Key Developments

• In September 2022, Royal DSM N.V. acquired Prodapv, Brazil’s leading animal nutrition and technology company.
• In August 2022, Medtronic plc acquired Affera Inc., a leading technology provider for treating cardiac arrhythmia.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Biomedical Textiles Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The porter’s five forces model can be used to assess the competitive landscape in the Global Biomedical Textiles Market, gauge the attractiveness of a certain sector, and assess investment possibilities.